US FDA expands use of Amgen, AstraZeneca's drug for sinus infection-March 2024-www.financetom.com

US FDA expands use of Amgen, AstraZeneca's drug for sinus infection

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA expands use of Amgen, AstraZeneca's drug for sinus infection

Oct 17, 2025 1:21 PM

Oct 17 (Reuters) - The U.S. Food and Drug Administration

has approved Amgen ( AMGN ) and AstraZeneca's ( AZN ) drug for a

type of chronic sinus infection, the drugmakers said on Friday.

Previous page： Next page：

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Mexico president says will not push successor to rush constitutional reforms

Jun 10, 2024

MEXICO CITY, June 10 (Reuters) - Mexico's outgoing president said he would not pressure his successor to rush a package of constitutional reforms he has proposed, including a major overhaul of the judiciary which has spooked markets since the June 2 election. President Andres Manuel Lopez Obrador said he would meet later on Monday with close ally Claudia Sheinbaum, who...